Top compounds associated with response to LINC01420


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA TAE684 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA EX-527 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.042 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.033 0.3
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA AZD0530 CCLE pan-cancer AAC -0.047 0.3
Download CSV